{
  "name": "diseasemodulediscovery-disease-networks",
  "title": "Disease Module Discovery: Network-Based Drug Repurposing",
  "description": "Identify disease modules and potential drug targets through network medicine approaches. Discover connected subnetworks of disease-associated genes in the human interactome using multiple validated algorithms (DOMINO, DIAMOnD, ROBUST). Perfect for drug repurposing and target identification.",
  "content": "<h1 class=\"heading-node\">ğŸ§¬ Disease Module Discovery: Network Medicine for Drug Repurposing</h1><p class=\"text-node\"><strong>Discover Disease Mechanisms and Drug Targets Through Network Analysis</strong></p><p class=\"text-node\">Disease Module Discovery uses network medicine principles to identify connected subnetworks (modules) of disease-associated genes within the human protein-protein interaction network. By analyzing the local neighborhood of disease genes (seeds) in the interactome, this pipeline reveals molecular mechanisms, identifies novel disease genes, and prioritizes drug candidates for repurposing.</p><img src=\"https://raw.githubusercontent.com/nf-core/diseasemodulediscovery/dev/docs/images/nf-core-diseasemodulediscovery_metro_map.png\" alt=\"Disease Module Discovery workflow\" width=\"800\" height=\"400\"><h2 class=\"heading-node\">ğŸ¯ What is Network Medicine?</h2><p class=\"text-node\">Network medicine recognizes that diseases rarely result from single gene abnormalities. Instead, diseases emerge from complex interactions among multiple genes and proteins. This pipeline:</p><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ” Identifies disease modules:</strong> Connected subnetworks enriched for disease-associated genes</p></li><li><p class=\"text-node\"><strong>ğŸ§¬ Discovers novel disease genes:</strong> Proteins that bridge known disease genes in the network</p></li><li><p class=\"text-node\"><strong>ğŸ’Š Prioritizes drug targets:</strong> Druggable proteins within or near disease modules</p></li><li><p class=\"text-node\"><strong>ğŸ”„ Enables drug repurposing:</strong> Identifies existing drugs targeting disease module proteins</p></li><li><p class=\"text-node\"><strong>ğŸ“Š Validates findings:</strong> Comprehensive evaluation through functional enrichment and topology analysis</p></li></ul><h2 class=\"heading-node\">ğŸ”¬ Multiple Algorithm Approach</h2><p class=\"text-node\">The pipeline integrates six complementary algorithms for robust module identification:</p><h3 class=\"heading-node\">Core Algorithms</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ¯ DOMINO:</strong> Active module identification using protein activity</p><ul class=\"list-node\"><li><p class=\"text-node\">Integrates expression data with network topology</p></li><li><p class=\"text-node\">Identifies modules with significant activity changes</p></li><li><p class=\"text-node\">Best for: Data-driven module discovery</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ’ DIAMOnD:</strong> DIseAse MOdule Detection algorithm</p><ul class=\"list-node\"><li><p class=\"text-node\">Iteratively expands from seed genes</p></li><li><p class=\"text-node\">Identifies proteins with significant connectivity to seeds</p></li><li><p class=\"text-node\">Best for: Seed-based module expansion</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ”§ ROBUST:</strong> Robust disease module miner</p><ul class=\"list-node\"><li><p class=\"text-node\">Identifies densely connected subnetworks</p></li><li><p class=\"text-node\">Optimizes for module robustness</p></li><li><p class=\"text-node\">Best for: Stable, high-confidence modules</p></li></ul></li><li><p class=\"text-node\"><strong>âš–ï¸ ROBUST (bias-aware):</strong> Bias-corrected version</p><ul class=\"list-node\"><li><p class=\"text-node\">Accounts for node degree bias in networks</p></li><li><p class=\"text-node\">Reduces false positives from hub proteins</p></li><li><p class=\"text-node\">Best for: Unbiased module detection</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ‘¥ 1st Neighbors:</strong> Direct interaction partners</p><ul class=\"list-node\"><li><p class=\"text-node\">Simple but effective baseline method</p></li><li><p class=\"text-node\">Includes all immediate neighbors of seed genes</p></li><li><p class=\"text-node\">Best for: Conservative, literature-supported expansion</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸš¶ Random Walk with Restart (RWR):</strong> Network diffusion</p><ul class=\"list-node\"><li><p class=\"text-node\">Simulates information flow through network</p></li><li><p class=\"text-node\">Identifies proteins in functional proximity to seeds</p></li><li><p class=\"text-node\">Best for: Capturing indirect functional relationships</p></li></ul></li></ul><p class=\"text-node\"><strong>Consensus benefits:</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">âœ… Robustness: Genes found by multiple methods are most reliable</p></li><li><p class=\"text-node\">âœ… Completeness: Different algorithms capture different aspects</p></li><li><p class=\"text-node\">âœ… Validation: Cross-method consistency increases confidence</p></li></ul><h2 class=\"heading-node\">ğŸ§ª Input Requirements</h2><h3 class=\"heading-node\">1. Seed Genes File (Required)</h3><p class=\"text-node\">A file listing your disease-associated genes (seeds) - one gene per line:</p><pre class=\"block-node\"><code># Example seeds.txt\nTP53\nBRCA1\nBRCA2\nPTEN\nEGFR</code></pre><p class=\"text-node\"><strong>Sources for seed genes:</strong></p><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ§¬ GWAS studies:</strong> Genome-wide association findings</p></li><li><p class=\"text-node\"><strong>ğŸ“Š Expression data:</strong> Differentially expressed genes</p></li><li><p class=\"text-node\"><strong>ğŸ”¬ Literature mining:</strong> Known disease genes from PubMed</p></li><li><p class=\"text-node\"><strong>ğŸ“š Disease databases:</strong> OMIM, DisGeNET, ClinVar, GWAS Catalog</p></li><li><p class=\"text-node\"><strong>ğŸ§® Variant analysis:</strong> Genes with disease-causing mutations</p></li></ul><p class=\"text-node\"><strong>Recommendations:</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Use gene symbols (HGNC nomenclature) or Entrez IDs</p></li><li><p class=\"text-node\">Include 10-100 seed genes (too few = incomplete; too many = diluted signal)</p></li><li><p class=\"text-node\">Focus on high-confidence disease associations</p></li><li><p class=\"text-node\">Consider tissue/context specificity</p></li></ul><h3 class=\"heading-node\">2. Network File (Optional)</h3><p class=\"text-node\">A tab-separated file defining protein-protein interactions:</p><pre class=\"block-node\"><code># Example network.tsv\nprotein1  protein2  confidence\nTP53      MDM2      0.95\nTP53      CDK2      0.87\nBRCA1     BRCA2     0.92</code></pre><p class=\"text-node\"><strong>If not provided:</strong> Pipeline uses default human interactome from NeDRex database</p><p class=\"text-node\"><strong>Custom networks:</strong> Use for organism-specific or tissue-specific analyses</p><h2 class=\"heading-node\">ğŸ“Š Comprehensive Output & Evaluation</h2><h3 class=\"heading-node\">Disease Module Results</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ§¬ Module gene lists:</strong> For each algorithm, genes included in disease module</p></li><li><p class=\"text-node\"><strong>ğŸ“Š Ranked candidates:</strong> Prioritized by connectivity and algorithm consensus</p></li><li><p class=\"text-node\"><strong>ğŸ¯ Consensus modules:</strong> Genes identified by multiple methods (highest confidence)</p></li><li><p class=\"text-node\"><strong>ğŸ“ˆ Module overlap analysis:</strong> Venn diagrams showing algorithm agreement</p></li></ul><h3 class=\"heading-node\">Functional Analysis</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ“š Pathway enrichment (g:Profiler):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Gene Ontology biological processes</p></li><li><p class=\"text-node\">KEGG pathways</p></li><li><p class=\"text-node\">Reactome pathways</p></li><li><p class=\"text-node\">Disease associations (DisGeNET)</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ” Functional coherence (DIGEST):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Quantifies biological relevance of modules</p></li><li><p class=\"text-node\">Compares to random gene sets</p></li><li><p class=\"text-node\">Validates disease specificity</p></li></ul></li></ul><h3 class=\"heading-node\">Network Topology Analysis</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ“Š Module density:</strong> How tightly connected are module genes?</p></li><li><p class=\"text-node\"><strong>ğŸ¯ Centrality metrics:</strong> Which genes are most important in the module?</p></li><li><p class=\"text-node\"><strong>ğŸŒ‰ Bridging analysis:</strong> Genes connecting different disease aspects</p></li><li><p class=\"text-node\"><strong>ğŸ“ˆ Statistical significance:</strong> Module properties vs random expectation</p></li></ul><h3 class=\"heading-node\">Robustness Evaluation</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ”€ Seed permutation (optional, --run_seed_permutation):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Tests module stability to seed perturbations</p></li><li><p class=\"text-node\">Evaluates seed rediscovery capability</p></li><li><p class=\"text-node\">Identifies robust vs fragile predictions</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ”€ Network permutation (optional, --run_network_permutation):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Tests module stability across network variations</p></li><li><p class=\"text-node\">Assesses algorithm sensitivity to network topology</p></li><li><p class=\"text-node\">Validates findings aren't artifacts of specific network</p></li></ul></li></ul><h3 class=\"heading-node\">Drug Repurposing Analysis</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸ’Š Drug prioritization (Drugst.One API):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Identifies FDA-approved drugs targeting module proteins</p></li><li><p class=\"text-node\">Ranks drugs by target coverage and relevance</p></li><li><p class=\"text-node\">Provides drug mechanisms and approval status</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ¯ Druggable target identification:</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Highlights proteins with known drug interactions</p></li><li><p class=\"text-node\">Identifies novel repurposing opportunities</p></li></ul></li></ul><h3 class=\"heading-node\">Visualization & Annotation</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>ğŸŒ Interactive network visualization (Drugst.One):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Web-based module exploration</p></li><li><p class=\"text-node\">Drug-target interaction overlays</p></li><li><p class=\"text-node\">Interactive filtering and analysis</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ“Š Static network plots (graph-tool, pyvis):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Publication-ready module networks</p></li><li><p class=\"text-node\">Seed highlighting and module boundaries</p></li><li><p class=\"text-node\">HTML interactive views</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ·ï¸ Biological annotation (NeDRexDB):</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">Drug targeting information</p></li><li><p class=\"text-node\">Side effect profiles</p></li><li><p class=\"text-node\">Disease associations</p></li><li><p class=\"text-node\">Cellular localization</p></li></ul></li><li><p class=\"text-node\"><strong>ğŸ“‹ BioPAX export:</strong> Standardized format for further analysis</p></li><li><p class=\"text-node\"><strong>ğŸ“ˆ MultiQC report:</strong> Comprehensive summary of all results and evaluations</p></li></ul><h2 class=\"heading-node\">ğŸ©º Applications & Use Cases</h2><h3 class=\"heading-node\">Drug Repurposing</h3><p class=\"text-node\">Identify existing FDA-approved drugs that target proteins within disease modules. Success examples include aspirin for cardiovascular disease, metformin for aging, and thalidomide for cancer.</p><h3 class=\"heading-node\">Target Discovery</h3><p class=\"text-node\">Reveal novel drug targets by identifying central proteins in disease modules that lack current therapeutics. Prioritize targets based on druggability and network position.</p><h3 class=\"heading-node\">Disease Mechanism Elucidation</h3><p class=\"text-node\">Understand molecular pathways driving disease by analyzing functional enrichment of disease modules. Identify which biological processes are disrupted.</p><h3 class=\"heading-node\">Biomarker Identification</h3><p class=\"text-node\">Discover proteins that could serve as diagnostic or prognostic biomarkers based on their central position in disease modules.</p><h3 class=\"heading-node\">Combination Therapy Design</h3><p class=\"text-node\">Identify complementary drug targets within modules to design rational combination therapies that target multiple aspects of disease.</p><h3 class=\"heading-node\">Precision Medicine</h3><p class=\"text-node\">Stratify patients based on their specific disease module profiles to enable personalized treatment selection.</p><h2 class=\"heading-node\">ğŸ¥ Disease Areas</h2><p class=\"text-node\"><strong>Successfully applied to:</strong></p><ul class=\"list-node\"><li><p class=\"text-node\">ğŸ«€ <strong>Cardiovascular diseases:</strong> Heart failure, atherosclerosis, arrhythmias</p></li><li><p class=\"text-node\">ğŸ§  <strong>Neurological disorders:</strong> Alzheimer's, Parkinson's, ALS, epilepsy</p></li><li><p class=\"text-node\">ğŸ—ï¸ <strong>Cancer:</strong> All cancer types, identifies oncogenic modules</p></li><li><p class=\"text-node\">ğŸ¦  <strong>Infectious diseases:</strong> COVID-19, HIV, tuberculosis</p></li><li><p class=\"text-node\">âš¡ <strong>Metabolic disorders:</strong> Diabetes, obesity, metabolic syndrome</p></li><li><p class=\"text-node\">ğŸ›¡ï¸ <strong>Autoimmune diseases:</strong> Rheumatoid arthritis, lupus, MS</p></li><li><p class=\"text-node\">ğŸ« <strong>Respiratory diseases:</strong> Asthma, COPD, pulmonary fibrosis</p></li><li><p class=\"text-node\">ğŸ§¬ <strong>Rare diseases:</strong> Orphan diseases with limited treatment options</p></li></ul><h2 class=\"heading-node\">âš™ï¸ Configuration Options</h2><h3 class=\"heading-node\">Module Inference</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>All algorithms enabled by default</strong></p></li><li><p class=\"text-node\"><strong>Selectively disable:</strong> --skip_domino, --skip_diamond, --skip_robust, etc.</p></li><li><p class=\"text-node\"><strong>Tune parameters:</strong> Module size limits, significance thresholds</p></li></ul><h3 class=\"heading-node\">Evaluation Options</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>--run_seed_permutation:</strong> Enable seed robustness testing (time-intensive)</p></li><li><p class=\"text-node\"><strong>--run_network_permutation:</strong> Enable network robustness testing (time-intensive)</p></li><li><p class=\"text-node\"><strong>Default:</strong> Both disabled for faster runtime; enable for publications</p></li></ul><h3 class=\"heading-node\">Drug Prioritization</h3><ul class=\"list-node\"><li><p class=\"text-node\"><strong>Automatic:</strong> Uses Drugst.One API for drug ranking</p></li><li><p class=\"text-node\"><strong>Filters:</strong> FDA-approved drugs, clinical trial drugs, experimental compounds</p></li></ul><h2 class=\"heading-node\">ğŸ“ˆ Expected Runtime & Resources</h2><ul class=\"list-node\"><li><p class=\"text-node\"><strong>â±ï¸ Quick run (no permutations):</strong> 30-60 minutes</p></li><li><p class=\"text-node\"><strong>â±ï¸ With seed permutation:</strong> 2-4 hours</p></li><li><p class=\"text-node\"><strong>â±ï¸ With network permutation:</strong> 4-8 hours</p></li><li><p class=\"text-node\"><strong>ğŸ’» Recommended:</strong> MEDIUM or LARGE node size</p></li><li><p class=\"text-node\"><strong>ğŸ’¾ Storage:</strong> 1-5 GB depending on network size</p></li></ul><h2 class=\"heading-node\">ğŸ“ Scientific Foundation</h2><p class=\"text-node\">This pipeline is developed by the <a class=\"link\" href=\"https://repo4.eu/\" target=\"_blank\">RePo4EU consortium</a>, a European initiative for drug repurposing using network medicine. The methods are based on peer-reviewed algorithms:</p><ul class=\"list-node\"><li><p class=\"text-node\">DOMINO: Leisure et al., PLOS Computational Biology 2015</p></li><li><p class=\"text-node\">DIAMOnD: Ghiassian et al., PLOS Computational Biology 2015</p></li><li><p class=\"text-node\">ROBUST: Baumbach et al., Bioinformatics 2019</p></li><li><p class=\"text-node\">Network medicine framework: BarabÃ¡si et al., Nature Reviews Genetics 2011</p></li></ul><h2 class=\"heading-node\">ğŸ”¬ Key References</h2><ul class=\"list-node\"><li><p class=\"text-node\">Network medicine approaches for drug repurposing</p></li><li><p class=\"text-node\">Disease module identification in human interactome</p></li><li><p class=\"text-node\">Computational drug target prioritization</p></li><li><p class=\"text-node\">Integration of multi-omics data with networks</p></li></ul><p class=\"text-node\"><strong>Developed for:</strong> Drug repurposing â€¢ Target discovery â€¢ Systems biology â€¢ Precision medicine â€¢ Translational research â€¢ Pharmaceutical R&D â€¢ Academic research â€¢ Clinical applications</p><p class=\"text-node\">Built with <a class=\"link\" href=\"https://www.nextflow.io/\" target=\"_blank\">Nextflow</a> â€¢ Powered by <a class=\"link\" href=\"https://nf-co.re/diseasemodulediscovery\" target=\"_blank\">nf-core/diseasemodulediscovery</a> â€¢ Developed by <a class=\"link\" href=\"https://repo4.eu/\" target=\"_blank\">RePo4EU consortium</a> â€¢ Containerized execution â€¢ Research-validated algorithms</p>",
  "imageUrl": "https://raw.githubusercontent.com/nf-core/diseasemodulediscovery/dev/docs/images/nf-core-diseasemodulediscovery_logo_light.png",
  "command": "nextflow run nf-core/diseasemodulediscovery --seeds ${seeds} --outdir ${outdir} -r dev -profile singularity",
  "engineType": "NEXTFLOW",
  "jobConfig": [
    {
      "type": "Select",
      "label": "System Size",
      "name": "system_size",
      "hidden": true,
      "description": "Select compute resources based on network size and evaluation options. MEDIUM recommended for standard analysis, LARGE for permutation testing.",
      "options": [
        {
          "label": "SMALL (8 CPUs, 30GB RAM) - Small seed sets (<20 genes)",
          "value": "small",
          "mapValue": {
            "nodeSize": "SMALL",
            "numNodes": 1,
            "withGpu": false
          }
        },
        {
          "label": "MEDIUM (32 CPUs, 120GB RAM) - Standard analysis (recommended)",
          "value": "medium",
          "mapValue": {
            "nodeSize": "MEDIUM",
            "numNodes": 1,
            "withGpu": false
          }
        },
        {
          "label": "LARGE (64 CPUs, 360GB RAM) - Large seed sets or permutation testing",
          "value": "large",
          "mapValue": {
            "nodeSize": "LARGE",
            "numNodes": 1,
            "withGpu": false
          }
        }
      ],
      "defaultValue": "medium"
    }
  ],
  "spec": [
    {
      "type": "Stash File",
      "label": "Seed Genes File",
      "name": "seeds",
      "description": "Text file with disease-associated genes (one per line). Use gene symbols (HGNC) or Entrez IDs. Recommended: 10-100 high-confidence disease genes from GWAS, expression studies, or disease databases.",
      "required": true,
      "hidden": false,
      "disabled": false,
      "restrictions": {
        "allow_files": true,
        "allow_folders": false,
        "allowed_file_types": [".txt", ".tsv", ".csv"]
      }
    },
    {
      "type": "Stash File",
      "label": "Network File (Optional)",
      "name": "network",
      "description": "Custom protein-protein interaction network (TSV: protein1, protein2, confidence). If not provided, default human interactome from NeDRex database will be used.",
      "required": false,
      "hidden": false,
      "disabled": false,
      "restrictions": {
        "allow_files": true,
        "allow_folders": false,
        "allowed_file_types": [".tsv", ".txt", ".csv"]
      }
    },
    {
      "type": "Stash File",
      "label": "Output Directory",
      "name": "outdir",
      "description": "Directory where disease modules, drug prioritization results, visualizations, and evaluation reports will be saved.",
      "defaultValue": "./diseasemodulediscovery-results",
      "required": true,
      "hidden": false,
      "disabled": false,
      "restrictions": {
        "allow_files": false,
        "allow_folders": true,
        "allowed_file_types": []
      }
    }
  ],
  "tags": [
    {"name": "network-medicine", "type": "subfield"},
    {"name": "drug-repurposing", "type": "task"},
    {"name": "systems-biology", "type": "subfield"},
    {"name": "biology", "type": "field"},
    {"name": "genomics", "type": "subfield"}
  ]
}
